Melanie Mala Makhija

Personal profile

Research Interests

I have clinical and research interests in food allergy including oral immunotherapy and epicutaneous immunotherapy, eosinophilic esophagitis, asthma and primary immunodeficiency. I am currently a primary and co-investigator on several multi-center national and international food allergy, immunology and asthma clinical trials.

Certifications and Licenses

	Pediatric Allergy & Immunology
	Allergy & Immunology
	Pediatrics

Training Experience

2008	Residency, Hospital for Sick Children, Canada
2010	Fellowship, Hospital for Sick Children, Canada

Education/Academic qualification

MD, University of Toronto

… → 2005

MS, London School of Hygiene and Tropical Medicine

… → 2001

Research interests

Allergies
Asthma
Eosinophilic Esophagitis
Food Allergy
Primary Immunodeficiency

Fingerprint Dive into the research topics where Melanie Mala Makhija is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

18 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

7 Active
37 Finished

Data, Modeling, and Coordination Center for PrecISE Network

Kumar, R. & Makhija, M. M.

University of North Carolina at Chapel Hill, National Heart, Lung, and Blood Institute

7/1/19 → 6/29/20

Project: Research project

Controlling and preventing Asthma progression and Severity in Kids (CASK)

Makhija, M. M., Pongracic, J. A. & Robison, R. G.

Children's Hospital, Boston, National Institute of Allergy and Infectious Diseases

5/1/19 → 6/30/23

Project: Research project

Controlling and preventing Asthma progression and Severity in Kids (CASK)

Makhija, M. M., Pongracic, J. A. & Robison, R. G.

Children's Hospital, Boston, National Institute of Allergy and Infectious Diseases

5/1/19 → 6/30/23

Project: Research project

ARC-008: A Multicenter, Open-label, Long-term Safety Study of AR101 Characterized Oral Desensitization Immunotherapy in Subjects who Participated in a Prior AR101 Study

Makhija, M. M., Pongracic, J. A. & Robison, R. G.

Aimmune Therapeutics, Inc.

12/8/17 → 12/7/20

Project: Research project

RPPR for Inner City Asthma consortium 3 (ICAC3)

Ariza, A. J., Makhija, M. M. & Pongracic, J. A.

University of Wisconsin-Madison, National Institute of Allergy and Infectious Diseases

8/1/16 → 7/31/21

Project: Research project

Research Output

504 Citations
18 Article
3 Letter
3 Review article
2 Chapter
3 More

A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic Individuals

Andorf, S., Purington, N., Kumar, D., Long, A., O'Laughlin, K. L., Sicherer, S., Sampson, H., Cianferoni, A., Whitehorn, T. B., Petroni, D., Makhija, M. M., Robison, R. G., Lierl, M., Logsdon, S., Desai, M., Galli, S. J., Rael, E., Assa'ad, A., Chinthrajah, S., Pongracic, J. A. & 5 others, Spergel, J. M., Tam, J., Tilles, S., Wang, J. & Nadeau, K., Jan 2019, In : EClinicalMedicine. 7, p. 27-38 12 p.